These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23499937)
1. ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons. Matsui H; Sato F; Sato S; Koike M; Taruno Y; Saiki S; Funayama M; Ito H; Taniguchi Y; Uemura N; Toyoda A; Sakaki Y; Takeda S; Uchiyama Y; Hattori N; Takahashi R FEBS Lett; 2013 May; 587(9):1316-25. PubMed ID: 23499937 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599 [TBL] [Abstract][Full Text] [Related]
3. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062 [TBL] [Abstract][Full Text] [Related]
4. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism. Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177 [TBL] [Abstract][Full Text] [Related]
5. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2. Park JS; Sue CM Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689 [TBL] [Abstract][Full Text] [Related]
6. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice. Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9). Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity. Usenovic M; Tresse E; Mazzulli JR; Taylor JP; Krainc D J Neurosci; 2012 Mar; 32(12):4240-6. PubMed ID: 22442086 [TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957 [TBL] [Abstract][Full Text] [Related]
11. Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish. Nyuzuki H; Ito S; Nagasaki K; Nitta Y; Matsui N; Saitoh A; Matsui H IBRO Rep; 2020 Dec; 9():1-8. PubMed ID: 32529115 [No Abstract] [Full Text] [Related]
12. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Ramirez A; Heimbach A; Gründemann J; Stiller B; Hampshire D; Cid LP; Goebel I; Mubaidin AF; Wriekat AL; Roeper J; Al-Din A; Hillmer AM; Karsak M; Liss B; Woods CG; Behrens MI; Kubisch C Nat Genet; 2006 Oct; 38(10):1184-91. PubMed ID: 16964263 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity. Usenovic M; Knight AL; Ray A; Wong V; Brown KR; Caldwell GA; Caldwell KA; Stagljar I; Krainc D Hum Mol Genet; 2012 Sep; 21(17):3785-94. PubMed ID: 22645275 [TBL] [Abstract][Full Text] [Related]
14. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Ramonet D; Podhajska A; Stafa K; Sonnay S; Trancikova A; Tsika E; Pletnikova O; Troncoso JC; Glauser L; Moore DJ Hum Mol Genet; 2012 Apr; 21(8):1725-43. PubMed ID: 22186024 [TBL] [Abstract][Full Text] [Related]
15. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review. Yang X; Xu Y Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640 [TBL] [Abstract][Full Text] [Related]
16. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene. Radi E; Formichi P; Di Maio G; Battisti C; Federico A J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566 [TBL] [Abstract][Full Text] [Related]